Article Details
Retrieved on: 2022-01-17 17:32:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The monoclonal antibody sotrovimab has also been conditionally recommended for treating mild or moderate COVID-19 in patients who are at high risk of ...
Article found on: pharmaceutical-journal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here